432 related articles for article (PubMed ID: 30946803)
21. Identification of Additional Anti-Persister Activity against Borrelia burgdorferi from an FDA Drug Library.
Feng J; Weitner M; Shi W; Zhang S; Sullivan D; Zhang Y
Antibiotics (Basel); 2015 Sep; 4(3):397-410. PubMed ID: 27025631
[TBL] [Abstract][Full Text] [Related]
22. Identification of new compounds with high activity against stationary phase Borrelia burgdorferi from the NCI compound collection.
Feng J; Shi W; Zhang S; Zhang Y
Emerg Microbes Infect; 2015 Jun; 4(6):e31. PubMed ID: 26954881
[TBL] [Abstract][Full Text] [Related]
23. Persistent Lyme Empiric Antibiotic Study Europe (PLEASE)--design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis.
Berende A; ter Hofstede HJ; Donders AR; van Middendorp H; Kessels RP; Adang EM; Vos FJ; Evers AW; Kullberg BJ
BMC Infect Dis; 2014 Oct; 14():543. PubMed ID: 25318999
[TBL] [Abstract][Full Text] [Related]
24. Activity of Sulfa Drugs and Their Combinations against Stationary Phase B. burgdorferi In Vitro.
Feng J; Zhang S; Shi W; Zhang Y
Antibiotics (Basel); 2017 Mar; 6(1):. PubMed ID: 28327498
[TBL] [Abstract][Full Text] [Related]
25. Lyme Borreliosis: Is there a preexisting (natural) variation in antimicrobial susceptibility among Borrelia burgdorferi strains?
Hodzic E
Bosn J Basic Med Sci; 2015 Jul; 15(3):1-13. PubMed ID: 26295288
[TBL] [Abstract][Full Text] [Related]
26. Metabolic Response in Patients With Post-treatment Lyme Disease Symptoms/Syndrome.
Fitzgerald BL; Graham B; Delorey MJ; Pegalajar-Jurado A; Islam MN; Wormser GP; Aucott JN; Rebman AW; Soloski MJ; Belisle JT; Molins CR
Clin Infect Dis; 2021 Oct; 73(7):e2342-e2349. PubMed ID: 32975577
[TBL] [Abstract][Full Text] [Related]
27. Follistatin-like protein 1 is a critical mediator of experimental Lyme arthritis and the humoral response to Borrelia burgdorferi infection.
Campfield BT; Nolder CL; Marinov A; Bushnell D; Davis A; Spychala C; Hirsch R; Nowalk AJ
Microb Pathog; 2014 Aug; 73():70-9. PubMed ID: 24768929
[TBL] [Abstract][Full Text] [Related]
28. Clinical manifestations, pathogenesis, and effect of antibiotic treatment on Lyme borreliosis in dogs.
Straubinger RK; Straubinger AF; Summers BA; Jacobson RH; Erb HN
Wien Klin Wochenschr; 1998 Dec; 110(24):874-81. PubMed ID: 10048169
[TBL] [Abstract][Full Text] [Related]
29. Influence of tick and mammalian physiological temperatures on Borrelia burgdorferi biofilms.
Shaikh S; Timmaraju VA; Torres JP; Socarras KM; Theophilus PAS; Sapi E
Microbiology (Reading); 2016 Nov; 162(11):1984-1995. PubMed ID: 27902419
[TBL] [Abstract][Full Text] [Related]
30. Cimetidine as a novel adjunctive treatment for early stage Lyme disease.
Shemenski J
Med Hypotheses; 2019 Jul; 128():94-100. PubMed ID: 27107653
[TBL] [Abstract][Full Text] [Related]
31. Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy.
Bockenstedt LK; Gonzalez DG; Haberman AM; Belperron AA
J Clin Invest; 2012 Jul; 122(7):2652-60. PubMed ID: 22728937
[TBL] [Abstract][Full Text] [Related]
32. A Review of Post-treatment Lyme Disease Syndrome and Chronic Lyme Disease for the Practicing Immunologist.
Wong KH; Shapiro ED; Soffer GK
Clin Rev Allergy Immunol; 2022 Feb; 62(1):264-271. PubMed ID: 34687445
[TBL] [Abstract][Full Text] [Related]
33. Superior efficacy of combination antibiotic therapy versus monotherapy in a mouse model of Lyme disease.
Alruwaili Y; Jacobs MB; Hasenkampf NR; Tardo AC; McDaniel CE; Embers ME
Front Microbiol; 2023; 14():1293300. PubMed ID: 38075920
[TBL] [Abstract][Full Text] [Related]
34. Antibody responses to Borrelia burgdorferi in patients with antibiotic-refractory, antibiotic-responsive, or non-antibiotic-treated Lyme arthritis.
Kannian P; McHugh G; Johnson BJ; Bacon RM; Glickstein LJ; Steere AC
Arthritis Rheum; 2007 Dec; 56(12):4216-25. PubMed ID: 18050219
[TBL] [Abstract][Full Text] [Related]
35. Serologic proteome analysis of Borrelia burgdorferi membrane-associated proteins.
Nowalk AJ; Gilmore RD; Carroll JA
Infect Immun; 2006 Jul; 74(7):3864-73. PubMed ID: 16790758
[TBL] [Abstract][Full Text] [Related]
36. A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library.
Feng J; Shi W; Zhang S; Sullivan D; Auwaerter PG; Zhang Y
Front Microbiol; 2016; 7():743. PubMed ID: 27242757
[TBL] [Abstract][Full Text] [Related]
37. Protective value of prophylactic antibiotic treatment of tick bite for Lyme disease prevention: an animal model.
Piesman J; Hojgaard A
Ticks Tick Borne Dis; 2012 Jun; 3(3):193-6. PubMed ID: 22421585
[TBL] [Abstract][Full Text] [Related]
38. Borrelia burgdorferi aggrecanase activity: more evidence for persistent infection in Lyme disease.
Stricker RB; Johnson L
Front Cell Infect Microbiol; 2013; 3():40. PubMed ID: 23967405
[TBL] [Abstract][Full Text] [Related]
39. Targeting of vascular adhesion protein-1 by positron emission tomography visualizes sites of inflammation in Borrelia burgdorferi-infected mice.
Siitonen R; Pietikäinen A; Liljenbäck H; Käkelä M; Söderström M; Jalkanen S; Hytönen J; Roivainen A
Arthritis Res Ther; 2017 Nov; 19(1):254. PubMed ID: 29166944
[TBL] [Abstract][Full Text] [Related]
40. Functional outcomes in patients with Borrelia burgdorferi reinfection.
Jares TM; Mathiason MA; Kowalski TJ
Ticks Tick Borne Dis; 2014 Feb; 5(1):58-62. PubMed ID: 24215678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
